The novel findings of this article are that RET inhibition impacts not only on primary tumour growth of ER-positive breast cancers but also on their metastatic dissemination, and that the promotion of migration and metastasis of ER-positive breast cancer cells promoted by IL-6 and RET signalling is mediated by FAK activity (Figure 1). Here, PTK2 is linked to neoplasm.